Abstract
Rationale
Oxytocin (OT), vasopressin (AVP) and 3,4 methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) all increase social interaction in rats, perhaps by enhancing the rewarding value of social encounters.
Objectives
Here, we used the conditioned place preference (CPP) paradigm to assess the intrinsic rewarding effects of OT, AVP and MDMA, and whether these effects are enhanced by the presence of a conspecific, or a dynamic, tactile object (a tennis ball).
Methods
Adult male rats received conditioning sessions in a CPP apparatus twice a day (vehicle at 10 a.m., drug at 3 p.m.). Experiment 1 involved conditioning with OT (0.5 mg/kg, intraperitoneal (i.p.)), AVP (0.005 mg/kg, i.p.) or MDMA (5 mg/kg, i.p.). Experiments 2 and 3 involved conditioning with the same treatments but in the presence of a conspecific receiving the same treatment (social-CPP) or in the presence of a tennis ball (object-CPP), respectively. Conditioned place preference was assessed 24 h, 2 weeks and 4 weeks later.
Results
OT, AVP and MDMA did not produce a conventional CPP. However, when the conditioning environment also contained a conspecific both OT and MDMA induced a significant CPP lasting for at least 4 weeks. Rats given OT and MDMA also developed a more modest yet significant CPP for the environment where they encountered a tennis ball.
Conclusions
These results indicate that OT and MDMA can augment the rewarding effects of social interaction, but also interaction with a dynamic and tactile non-social object. AVP does not condition social- or object-CPPs and may promote social proximity by inducing generalized anxiety and defensive aggregation.
Similar content being viewed by others
References
Aguilar MA, Rodriguez-Arias M, Minarro J (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59:253–277
Baracz SJ, Rourke PI, Pardey MC, Hunt GE, McGregor IS, Cornish JL (2012) Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behav Brain Res 228:185–193
Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73–83
Bethlehem RA, Baron-Cohen S, van Honk J, Auyeung B, Bos PA (2014) The oxytocin paradox. Front Behav Neurosci 8:48
Beurel E, Nemeroff CB (2014) Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour. Curr Top Behav Neurosci 18:67–80
Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 1:1306–1311
Bielsky IF, Young LJ (2004) Oxytocin, vasopressin, and social recognition in mammals. Peptides 25:1565–1574
Bielsky IF, Hu S, Ren X, Terwilliger EF, Young LJ (2005) The V1a Vasopressin Receptor Is Necessary and Sufficient for Normal Social Recognition: A Gene Replacement Study. Neuron 47:503–513.
Bilsky EJ, Montegut MJ, Nichols ML, Reid LD (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59:215–220
Bowen MT, McGregor IS (2014) Oxytocin and vasopressin modulate the social response to threat: a preclinical study. Int J Neuropsychopharmacol 17:1621–1633
Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS (2011) Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS ONE 6:e27237
Brielmaier JM, McDonald CG, Smith RF (2008) Nicotine place preference in a biased conditioned place preference design. Pharmacol Biochem Behav 89:94–100
Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS (2003) Heat increases 3, 4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol 482:339–341
Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology 91: 363–368
Dantzer R, Koob GF, Le Moal M (1988) Septal vasopressin modulates social memory in male rats. Brain Res 457:143–147
Dolen G, Darvishzadeh A, Huang KW, Malenka RC (2013) Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501:179–18
Domes G, Sibold M, Schulze L, Lischke A, Herpertz S, Heinrichs M (2012) Intranasal oxytocin increases covert attention to positive social cues. Psychol Med 12:1–8
Douglas LA, Varlinskaya EI, Spear LP (2004) Rewarding properties of social interactions in adolescent and adult male and female rats: impact of social versus isolate housing of subjects and partners. Dev Psychobiol 45:153–162
Egashira N, Tanoue A, Matsuda T, Koushi E, Harada S, Takano Y, Tsujimoto G, Mishima K, Iwasaki K, Fujiwara M (2007) Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav Brain Res 178:123–127
Ettenberg A, Van Der Kooy D, Le Moal M, Koob GF, Bloom FE (1983) Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? Behav Brain Res 7:331–350
Frye CG, Wardle MC, Norman GJ, de Wit H (2014) MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav 117:1–6
Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol Rev 55:463–508
Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand J-P, Soubrié P (2002) Anxiolytic-and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99:6370–6375
Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L, Grunder G, Spreckelmeyer KN (2013) Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol Psychiatry 74:172–179
Harris G (2004) What all social workers should know about MDMA (Ecstasy). J Soc Work Pract Addict 4:23–37
Heinrichs M, von Dawans B, Domes G (2009) Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 30:548–557
Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M (1998) Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet 351:1784
Herzig V, Capuani E, Kovar KA, Schmidt W (2005) Effects of MPEP on expression of food‚ MDMA amphetamine conditioned place preference in rats. Addict Biol 10:243–249
Hicks C, Ramos L, Reekie T, Misagh G, Narlawar R, Kassiou M, McGregor I (2014) Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br J Pharmacol 171:2868–2887
Hunt GE, McGregor IS, Cornish JL, Callaghan PD (2011) MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Res Bull 86:65–73
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25:11489–11493
Liberzon I, Trujillo KA, Akil H, Young EA (1997) Motivational properties of oxytocin in the conditioned place preference paradigm. Neuropsychopharmacology 17:353–359
Lukas M, Neumann ID (2012) Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav Brain Res 251:85–94
Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID (2011) The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 36:2159–2168
MacDonald K, Feifel D (2012) Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr 24:130–146
Madularu D, Athanassiou M, Yee JR, Mumby DG (2014) Centrally-administered oxytocin promotes preference for familiar objects at a short delay in ovariectomized female rats. Behav Brain Res 274:164–167
Mak P, Broussard C, Vacy K, Broadbear JH (2012) Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J Psychopharmacol 26:532–542
Marshall AD (2013) Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin. Biol Psychol 93:296–303
Meyer A, Mayerhofer A, Kovar K-A, Schmidt WJ (2002) Rewarding effects of the optical isomers of 3, 4-methylenedioxy-methylamphetamine (Ecstasy) and 3, 4-methylenedioxy-ethylamphetamine (Eve) measured by conditioned place preference in rats. Neurosci Lett 330:280–284
Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524–538
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28–39
Morhenn V, Beavin LE, Zak PJ (2012) Massage increases oxytocin and reduces adrenocorticotropin hormone in humans. Altern Ther Health Med 18:11–18
Morley KC, McGregor IS (2000) (±)-3, 4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Eur J Pharmacol 408:41–49
Neumann ID, Landgraf R (2012) Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 35:649–659
Peartree NA, Hood LE, Thiel KJ, Sanabria F, Pentkowski NS, Chandler KN, Neisewander JL (2012) Limited physical contact through a mesh barrier is sufficient for social reward-conditioned place preference in adolescent male rats. Physiol Behav 105:749–756
Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M, McGregor IS (2013) Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3, 4-Methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 38:2249–2259
Rodriguez-Arias M, Valverde O, Daza-Losada M, Blanco-Gandia MC, Aguilar MA, Minarro J (2013) Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 47:77–84
Simmler LD, Hysek CM, Liechti ME (2011) Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab 96:2844–2850
Tai K, Zheng X, Narayanan J (2011) Touching a teddy bear mitigates negative effects of social exclusion to increase prosocial behavior. Soc Psychol Personal Sci 2:618–626
Thiel KJ, Okun AC, Neisewander JL (2008) Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats. Drug Alcohol Depend 96:202–212
Thompson M, Callaghan P, Hunt G, Cornish J, McGregor I (2007) A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine ('Ecstasy'). Neuroscience 146:509–514
Thompson M, Hunt G, McGregor I (2009) Neural correlates of MDMA ('Ecstasy')-induced social interaction in rats. Soc Neurosci 4:60–72
Tops M, Koole SL, IJzerman H, Buisman-Pijlman FT (2013) Why social attachment and oxytocin protect against addiction and stress: insights from the dynamics between ventral and dorsal corticostriatal systems. Pharmacol Biochem Behav 119:39–48
Toth I, Neumann ID, Slattery DA (2012) Social fear conditioning: a novel and specific animal model to study social anxiety disorder. Neuropsychopharmacology 37:1433–1443
Trezza V, Damsteegt R, Vanderschuren LJMJ (2009) Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate. Eur Neuropsychopharmacol 19:659–669
Tzschentke TM (2007) Review on CPP: measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227–462
Uvnas-Moberg K (1998) Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 23:819–835
Veenema AH, Bredwold R, De Vries GJ (2011) Vasopressin regulates social recognition in juvenile and adult rats of both sexes, but in sex- and age-specific ways. Horm Behav 61:50–56.
Wardle MC, de Wit H (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231:4219–4229
Wardle MC, Kirkpatrick MG, de Wit H (2014) 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci 9:1076–1081
Wilcox RR (1987) New designs in analysis of variance. Annu Rev Psychol 38:29–60
Williams JR, Insel TR, Harbaugh CR, Carter CS (1994) Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol 6:247–250
Winslow JT (1993) A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 365:545–547
Zakharova E, Miller J, Unterwald E, Wade D, Izenwasser S (2009) Social and physical environment alter cocaine conditioned place preference and dopaminergic markers in adolescent male rats. Neuroscience 163:890–897
Acknowledgments
Research supported by funding from the National Health and Medical Research Council of Australia (NHMRC; project grants 1011518 and 1033444). Linnet Ramos is the recipient of a University of Sydney World Scholars Award. Iain S. McGregor was supported by an Australian Professorial Fellowship from the Australian Research Council and is currently an NHMRC Principal Research Fellow. All animal experiments conducted in this study comply with the Australian code for the care and use of animals for scientific purposes.
Funding and grants
This research was supported by National Health and Medical Research Council grants 1033444 and 1011518.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramos, L., Hicks, C., Caminer, A. et al. Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats. Psychopharmacology 232, 2631–2641 (2015). https://doi.org/10.1007/s00213-015-3899-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-015-3899-9